Skip to main content

Cardinal Health guidance

  • CAH · NYSE
  • Distribution
  • Health Care Distributors
  • S&P 500
$283.85+0.98%Close 16 Nov 2026 · Market value $65.13B

In its results release of 5 Nov 2026 (Q1 FY2027), Cardinal Health gave 2 forecasts in figures, among them EPS (adjusted) of $12.80 to $13.00 for FY2027.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q1 FY2027 results, 5 Nov 2026

MeasurePeriodGuidanceAs stated
EPS · Adjusted · RaisedFY2027$12.80 to $13.00Cardinal Health raises fiscal year 2027 non-GAAP EPS guidance 2 to $12.80 to $13.00, 17% to 19% growth 3 from its FY26 ex-tariff refund baseline and 14% to 15% growth from reported FY26 results
EPS growth · AdjustedFY2027+17% to +19%Cardinal Health raises fiscal year 2027 non-GAAP EPS guidance 2 to $12.80 to $13.00, 17% to 19% growth 3 from its FY26 ex-tariff refund baseline and 14% to 15% growth from reported FY26 results

Source: the company's earnings release.

Guidance against results above 1 · within 1 · below 0

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
EPS growth · AdjustedFY2027+17% to +19%Raised once—To come
EPS · AdjustedFY2027$12.80 to $13.00Raised once—To come
Free cash flow · AdjustedFY2027$3.50B to $4.00BGiven once—To come
Capital expendituresFY2027$700MGiven once—To come
Tax rate · AdjustedFY202719% to 20%Given once—To come
EPS · AdjustedFY2026$10.70 to $10.80Raised 4 times$11.26Above the range
Capital expendituresFY2026$600M to $650MRaised once$649MWithin the range

CAH in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.